Lazertinib

SI-7847

Lazertinib, >98% (HPLC)

CAS No. : [1903008-80-9]

Synonyms : YH-25448; GNS-1480

IUPAC Name : N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Lazertinib is a BBB‑penetrant third‑generation EGFR‑TKI that also inhibits ABCB1/ABCG2 and activates TRPA1, inducing antitumor, chemosensitizing, and sensory‑neuron effects.

References : Yun J. et al.: Clin. Cancer Res., 25(8), 2575-2587, 2019.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.